Home / Author Archives: bio972 (page 4)

Author Archives: bio972

Mazor Robotics Promotes Christopher Prentice To CEO Of Its US Subsidiary מזור רובוטיקה מקדמת כריסטופר פרנטיס למנכ"ל החברה הבת בארה"ב

Mazor Robotics Ltd. (TASE:MZOR, NASDAQ:MZOR) of Caesarea has promoted Christopher Prentice, SVP America & Global Marketing, to CEO of its United States subsidiary, Mazor Robotics, Inc. He will report directly to Ori Hadomi, CEO of the parent company, who made the following statement: ...

Read More »

Scientists at Weizmann Develop Adaptive Optics Microscope that Focuses Through Thick Layers מדענים בויצמן המציאו מיקרוסקופ עם אופטיקה מסתגלת המסוגלת להתמקד דרך שכבות עבות

Study of diseased tissue and biological samples through a microscope can often be complicated by multiple layers of surrounding tissues. The resulting image may be too distorted to be of any value. Although there are modern microscopes that compensate for this using fluorescent ...

Read More »

Beta-O2 Technologies Ltd. Receives Grant from JDRF to Advance Clinical Development of Bio-Artificial Pancreas בטא-02 טכנולוגיות בע"מ קבל מענק כדי לקדם את הפיתוח קליני של לבלב ביו-מלאכותי

Patients with type 1 diabetes (T1D) may be able to look forward to a life without frequent glucose tests and insulin injections. Israeli biomedical company Beta-O2 Technologies Ltd. has announced that the company received a $500K grant from global diabetes organization JDRF ...

Read More »

Researchers at Bar Ilan University Find Epigenetic Link Between Mother’s Diet and Offspring’s Risk of Obesity חוקרים באוניברסיטת בר אילן מצאו קשר אפיגנטי בין התזונה של האם והסיכון להשמנת ילדיה

Does a mother’s diet affect her child’s risk of obesity? A recent study at Bar Ilan University’s Faculty of Life Sciences shows evidence of an epigenetic link. Published in the September 2014 issue of The FASEB Journal, the research used ...

Read More »

Teva Pharmaceutical Industries (NYSE:TEVA; TASE:TEVA) Recalls Parkinson’s Disease Medication טבע תעשיות פרמצבטיות מבצעת ריקול בתרופה למחלת פרקינסון

Teva Pharmaceutical Industries Ltd. is issuing a Class II recall of one lot (3,881 bottles) of carbidopa/levodopa 25 mg/100 mg, a generic drug used to treat Parkinson’s disease, due to the potential for “superpotent” tablets. The lot in question was manufactured ...

Read More »